Regulatory PathRegulatory requirements compared

Active substance

Estrone

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
THEELIN1MG/ML; 2MG/ML; 5MG/MLinjectable · injectionPARKEDALEDiscontinued12 Jun 1941
ESTRONE5MG/MLinjectable · injectionDR REDDYSDiscontinued21 Feb 1979
ESTRONE2MG/MLinjectable · injectionWATSON LABSDiscontinued
ESTROGENIC SUBSTANCE2MG/MLinjectable · injectionWYETH AYERSTDiscontinued
NATURAL ESTROGENIC SUBSTANCE-ESTRONE2MG/MLinjectable · injectionWATSON LABSDiscontinued

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
ESTRAGYN VAGINAL CREAM007273690.1 % / W/WCREAM · VAGINALSEARCHLIGHT PHARMA INC

Safety signals and safety-related labeling changes

All safety entries for estrone →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.